Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Beclometasone 5mg gastro-resistant modified-release tablets
0105020G0AAAAAA
|
Beclometasone dipropionate (Systemic) | Beclometasone dipropionate (Systemic) | Gastro-Intestinal System | 500 |
|
Ispagel Orange 3.5g effervescent granules sachets
0106010E0BJAAAD
|
Ispagel Orange | Ispaghula husk | Gastro-Intestinal System | 499 |
|
Mesalazine 1.6g gastro-resistant tablets
0105010B0AABDBD
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 499 |
|
Dicycloverine 10mg/5ml oral solution
0102000J0AAAAAA
|
Dicycloverine hydrochloride | Dicycloverine hydrochloride | Gastro-Intestinal System | 493 |
|
Lansoprazole 15mg/5ml oral solution
0103050L0AAAMAM
|
Lansoprazole | Lansoprazole | Gastro-Intestinal System | 493 |
|
Sterculia 62% granules 7g sachets gluten free
0106010N0AAADAD
|
Sterculia (Bulk Forming) | Sterculia | Gastro-Intestinal System | 491 |
|
Audmonal Forte 120mg capsules
0102000A0BDABAB
|
Audmonal | Alverine citrate | Gastro-Intestinal System | 489 |
|
Hyoscine butylbromide 10mg/5ml oral suspension
0102000N0AAAQAQ
|
Hyoscine butylbromide | Hyoscine butylbromide | Gastro-Intestinal System | 488 |
|
Mesalazine 4g modified-release granules sachets sugar free
0105010B0AABABA
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 481 |
|
Sterculia 62% granules gluten free
0106010N0AAAAAA
|
Sterculia (Bulk Forming) | Sterculia | Gastro-Intestinal System | 480 |
|
diabact UBT 50mg tablets
010300000BBADAD
|
Proprietary compound preparation BNF 0103000 | Other test for helicobacter pylori preparations | Gastro-Intestinal System | 479 |
|
Imodium Original 2mg capsules
0104020L0BBAAAA
|
Imodium | Loperamide hydrochloride | Gastro-Intestinal System | 473 |
|
Urea [13-C] 50mg tablets breath test kit
010300000AAADAD
|
Generic compound preparation BNF 0103000 | Other test for helicobacter pylori preparations | Gastro-Intestinal System | 470 |
|
Pancrease HL gastro-resistant capsules
0109040N0BFABAS
|
Pancrease | Pancreatin | Gastro-Intestinal System | 469 |
|
Prednisolone 20mg/100ml rectal solution
0105020E0AAABAB
|
Prednisolone sodium phosphate (Rectal) | Prednisolone sodium phosphate | Gastro-Intestinal System | 460 |
|
Plenvu oral powder sachets
010604000BBAAA0
|
Proprietary compound preparation BNF 0106040 | Other osmotic laxative preparations | Gastro-Intestinal System | 450 |
|
Assicco 2mg tablets
0102000L0BDABAA
|
Assicco | Glycopyrronium bromide | Gastro-Intestinal System | 445 |
|
Loperamide 2mg / Simeticone 125mg tablets
0104020P0AAAAAA
|
Loperamide hydrochloride/simeticone | Loperamide hydrochloride and simeticone | Gastro-Intestinal System | 442 |
|
Glycopyrronium bromide 1mg/5ml oral liquid
0102000L0AAADAD
|
Glycopyrronium bromide (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | 440 |
|
Normacol Plus granules 7g sachets
0106010N0BBADAF
|
Normacol | Sterculia | Gastro-Intestinal System | 439 |
|
Jorveza 1mg orodispersible tablets
0105020A0BEAAAG
|
Jorveza | Budesonide | Gastro-Intestinal System | 431 |
|
Norimode 2mg tablets
0104020L0BIAAAD
|
Norimode | Loperamide hydrochloride | Gastro-Intestinal System | 431 |
|
Salofalk 250mg gastro-resistant tablets
0105010B0BDAAAH
|
Salofalk | Mesalazine (Systemic) | Gastro-Intestinal System | 425 |
|
Magnesium oxide 160mg capsules
0101010I0AAACAC
|
Magnesium oxide | Magnesium oxide | Gastro-Intestinal System | 424 |
|
Cortiment 9mg modified-release tablets
0105020A0BDAAAF
|
Cortiment | Budesonide | Gastro-Intestinal System | 415 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.